Cited by 122Patient-Provider Communication in HealthcareDecision-Making and Behavioral EconomicsRisk Perception and Management

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Doctors and Patients’ Susceptibility to Framing Bias: A Randomized Trial

Open access
Perneger, Thomas V., Agoritsas, Thomas·2011·Journal of General Internal Medicine

Abstract

Background Framing of risk influences the perceptions of treatment benefit. Objective To determine which risk framing format corresponds best to comprehensive multi-faceted information, and to compare framing bias in doctors and in patients. Design Randomized mail surveys. Participants One thousand four hundred and thirty-one doctors (56% response rate) and 1121 recently hospitalized patients (65% response rate). Intervention Respondents were asked to interpret the results of a hypothetical clinical trial comparing an old and a new drug. They were randomly assigned to the following framing formats: absolute survival (new drug: 96% versus old drug: 94%), absolute mortality (4% versus 6%), relative mortality reduction (reduction by a third) or all three (fully informed condition). The new drug was reported to cause more side-effects. Main measure Rating of the new drug as more effective than the old drug. Results The proportions of doctors who rated the new drug as more effective varied by risk presentation format (abolute survival 51.8%, absolute mortality 68.3%, relative mortality reduction 93.8%, and fully informed condition 69.8%, p < 0.001). In patients these proportions were similar (abolute survival 51.7%, absolute mortality 66.8%, relative mortality reduction 89.3%, and fully informed condition 71.2%, p < 0.001). In both doctors (p = 0.72) and patients (p = 0.23) the fully informed condition was similar to the absolute risk format, but it differed significantly from the other conditions (all p < 0.01). None of the differences between doctors and patients were significant (all p > 0.1). In comparison to the fully informed condition, the odds ratio of greater perceived effectiveness was 0.45 for absolute survival (p < 0.001), 0.89 for absolute mortality (p = 0.29), and 4.40 for relative mortality reduction (p < 0.001). Conclusions Framing bias affects doctors and patients similarly. Describing clinical trial results as absolute risks is the least biased format, for both doctors and patients. Presenting several risk formats (on both absolute and relative scales) should be encouraged.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11606-011-1810-x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 26

  1. McGettigan P, Sly K, O’Connell D, Hill S, Henry D. The effects of information framing on the practices of physicians. J Gen Intern Med 1999;14:633–42 · DOI
  2. Edwards A, Elwyn G, Covey J, Matthews E, Pill R. Presenting risk information: a review of the effects of framing and other manipulations on patient outcomes. J Health Commun 2001;6:61–82 · DOI
  3. Moxey A, Dip G, O’Connell D, McGettigan P. Describing treatment effects to patients: How they are expressed makes a difference. J Gen Intern Med 2003;18:948–95 · DOI
  4. Covey J. A meta-analysis of the effects of presenting treatment benefits in different formats. Med Decis Making 2007;27:638–54 · DOI
  5. Malenka DJ, Baron JA, Johansen S, Wahrenberger JW, Ross JM. The framing effect of relative and absolute risk. J Gen Intern Med 1993;8:543–8 · DOI
  6. Hux JE, Naylor CD. Communicating the benefits of chronic preventive therapy: does the format of efficacy data determine patients’ acceptance of treatment? Med Decis Making 1995;15:152–7 · DOI
  7. Misselbrook D, Armstrong D. Patients’ responses to risk information about the benefits of treating hypertension. Br J Gen Practice 2001;51:276–9
  8. Chao C, Studts JL, Abell T et al. Adjuvant chemotherapy for breast cancer : how presentation of recurrence risk influences decision-making. J Clin Oncol 2003;21:4299–305 · DOI
  9. Carling CLL, Kristoffersen DT, Montori VM et al. The effect of alternative summary statistics for communicating risk reduction on decisions about taking statins: a randomized trial. PLOS Med 2009;6:e1000134 · DOI
  10. Bucher HC, Weinbacher M, Gyr K. Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration. BMJ 1994;309:761–4 · DOI
  11. Epstein RM, Alper BS, Quill TE. Communicating evidence for participatory decision making. JAMA 2004;291:2359–66 · DOI
  12. Gigerenzer G, Wegwarth O, Feufel M. Misleading communication of risk. BMJ 2010;341:791–2 · DOI
  13. Schwartz PH, Meslin EM. The ethics of information: absolute risk reduction and patient understanding of screening. J Gen Intern Med 2008;23:867–70 · DOI
  14. Edwards A, Elwyn G. Understanding risk and lessons for clinical risk communication about treatment preferences. Qual Health Care 2001;10(Suppl 1):i9-i13 · DOI
  15. Stovring H, Gyrd-Hansen D, Kristiansen IS, Nexoe J, Nielsen JB. Communicating effectiveness of intervention for chronic diseases: what single format can replace comprehensive information? BMC Med Inform Decis Making 2008;8:25 · DOI
  16. Carling CLL, Kristoffersen DT, Oxman AD et al. The effect of how outcomes are framed on decisions about whether to take antihypertensive medication: a randomized trial. PLOS One 2010;5:e9469 · DOI
  17. Armstrong K, Schwartz JS, Fitzgerald G, Putt M, Ubel PA. Effect of framing as gain versus loss on understanding and hypothetical treatment choices: survival and mortality curves. Med Decis Making 2002;22:76–83 · DOI
  18. Peters E, Hart PS, Fraenkel L. Informing patients: the influence of numeracy, framing, and format of side effect information on risk perceptions. Med Decis Making. 2010; (epub). · DOI
  19. Deom M, Agoritsas T, Perneger TV. What doctors think about the impact of managed care tools on quality of care, costs, autonomy, and relations with patients. BMC Health Services Res 2010;10:331 · DOI
  20. Agoritsas T, Courvoisier DS, Combescure C, Deom M, Perneger TV. Does prevalence matter to physicians in estimating post-test probability? A randomized trial. J Gen Intern Med 2011;26:373–8 · DOI
  21. Agoritsas T, Perneger TV. Patient-reported conformity of informed consent procedures and participation in clinical research. QJM Int J Med 2011;104:151–9. · DOI
  22. Agoritsas T, Deom M, Perneger TV. Study design attributes influenced patients’ willingness to participate in clinical research: a randomized vignette-based study. J Clin Epidemiol. 2011;64–107. · DOI
  23. Lee ET. Statistical Methods for Survival Data Analysis. 2nd edition. New York: John Wiley & Sons, 1992, p 133.
  24. Young JM, Glasziou P, Ward JE. eneral practitioners’ self ratings of skills in evidence based medicine: validation study. BMJ. 2002;324:950–951. · DOI
  25. Puhan MA, Steurer J, Bachmann LM, ter Riet G. A randomized trial of ways to describe test accuracy: the effect on physicians' post-test probability estimates. Ann Intern Med 2005;143:184–9. · DOI
  26. Sox CM, Doctor JN, Koepsell TD, Christakis DA. The influence of types of decision support on physicians' decision making. Arch Dis Child 2009;94:185–90. · DOI

Cited by

Sorted by citations

Metadata

Authors
Perneger, T. V., & Agoritsas, T.
Affiliations
University of Geneva (CH)
Corresponding author
Perneger, Thomas V.
Venue
Journal of General Internal Medicine
Published
2011-07-27
Volume
26
Issue
12
Pages
1411-1417
ISSN
  • 0884-8734 (ISSN-L)
  • 1525-1497
OpenAlex
W2039726724
Cited by
122
References
1
Citations by year
2026: 9 · 2025: 6 · 2024: 6 · 2023: 8 · 2022: 26 · 2021: 7 · 2020: 13 · 2019: 13 · 2018: 7 · 2017: 7 · 2016: 5 · 2015: 4 · 2014: 7 · 2013: 2 · 2012: 1
FWCI
6.54
Type
journal article
Language
en
Open access
Locations
  • Journal of General Internal Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
  • reroDoc Digital Library (submittedVersion)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
Topics
  • Health Sciences › Health Professions › General Health Professions › Patient-Provider Communication in Healthcare
  • Social Sciences › Decision Sciences › General Decision Sciences › Decision-Making and Behavioral Economics
  • Social Sciences › Sociology and Political Science › Risk Perception and Management
Keywords
framing bias, risk communication, absolute risk, relative risk reduction, perceived treatment effectiveness, clinical trial results
MeSH terms
Adult, Data Collection, Female, Humans, Male, Middle Aged, Patient Participation, Perception, Physician's Role, Bias, Treatment Outcome, Patient Preference

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review